Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Barry E Gidal

Showing results (11-20 of 87) with videos related to

Pageof 9
Sort By:
Epilepsy Research|January 18, 2006
Drug absorption in the elderly: biopharmaceutical considerations for the antiepileptic drugsBarry E Gidal
Epilepsy Currents|June 19, 2014
P-glycoprotein Expression and Pharmacoresistant Epilepsy: Cause or Consequence?Barry E Gidal
Epilepsy Currents|August 29, 2015
Phenytoin Hypersensitivity: It's Time for Some IndividualityBarry E Gidal
Stroke|September 30, 2005
Phenytoin and cognitive declineSebastian Koch, Barry E Gidal
Epilepsia|December 18, 2008
Debate: Substitution of generic drugs in epilepsy: is there cause for concern?Barry E Gidal, Torbjörn Tomson
The Annals of Pharmacotherapy|November 26, 2009
The effect of carbapenem antibiotics on plasma concentrations of valproic acidErin E Mancl, Barry E Gidal
Clinical Therapeutics|July 18, 2003
Gabapentin dosing in the treatment of epilepsyMichael J McLean, Barry E Gidal
Neurologic Clinics|October 21, 2022
Rescue Treatments for Seizure ClustersRobert J Kotloski, Barry E Gidal
Neurology|April 19, 2019
Lamotrigine and hemophagocytic lymphohistiocytosisKimford J Meador, Barry E Gidal
Epilepsy & Behavior : E&B|November 8, 2017
When adverse effects are seen as desirable: Abuse potential of the newer generation antiepileptic drugsKelsey L Hawkins, Barry E Gidal
Pageof 9

Showing results (11-20 of 87) with videos related to

Sort By:
Pageof 9
Epilepsy Research|January 18, 2006
Drug absorption in the elderly: biopharmaceutical considerations for the antiepileptic drugsBarry E Gidal
Epilepsy Currents|June 19, 2014
P-glycoprotein Expression and Pharmacoresistant Epilepsy: Cause or Consequence?Barry E Gidal
Epilepsy Currents|August 29, 2015
Phenytoin Hypersensitivity: It's Time for Some IndividualityBarry E Gidal
Stroke|September 30, 2005
Phenytoin and cognitive declineSebastian Koch, Barry E Gidal
Epilepsia|December 18, 2008
Debate: Substitution of generic drugs in epilepsy: is there cause for concern?Barry E Gidal, Torbjörn Tomson
The Annals of Pharmacotherapy|November 26, 2009
The effect of carbapenem antibiotics on plasma concentrations of valproic acidErin E Mancl, Barry E Gidal
Clinical Therapeutics|July 18, 2003
Gabapentin dosing in the treatment of epilepsyMichael J McLean, Barry E Gidal
Neurologic Clinics|October 21, 2022
Rescue Treatments for Seizure ClustersRobert J Kotloski, Barry E Gidal
Neurology|April 19, 2019
Lamotrigine and hemophagocytic lymphohistiocytosisKimford J Meador, Barry E Gidal
Epilepsy & Behavior : E&B|November 8, 2017
When adverse effects are seen as desirable: Abuse potential of the newer generation antiepileptic drugsKelsey L Hawkins, Barry E Gidal
Pageof 9